"Dr Reddy"
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
You Might Like
Dr Reddy’s initiates voluntary recall of Sapropterin Dihydrochloride in US over potency concernsIndiaTimes - Published | |
Dr Reddy’s rolls out migraine management device Nerivio in EuropeIndiaTimes - Published | |
Dr Reddy's to exclusively distribute Sanofi's vaccine portfolio in IndiaDr Reddy’s Laboratories on Wednesday informed the bourses has entered into an exclusive partnership with Sanofi Healthcare India Pvt Ltd for the distribution of the latter’s vaccine portfolio in..IndiaTimes - Published | |
Dr Reddy's ties up with US firm for resuscitative therapyIndiaTimes - Published | |
Megha, Yashoda hospital, pharma companies kept BRS in good healthMEIL was the biggest donor to BRS with Rs 195 crore. Yashoda Hospital followed with Rs 94 crore. Dr Reddy’s Lab and Hetero Drugs contributed Rs 32 crore and Rs 30 crore, respectively.IndiaTimes - Published | |
BJP, BRS & Cong top recipients of donations from pharma firmsBJP, BRS, Congress dominated pharma donations through electoral bonds, with BJP receiving the highest amount. Aurobindo Pharma, whose director was arrested in an excise scam, is also one of the donors..IndiaTimes - Published | |
Booster shot: Sector biggies to make Uttar Pradesh a pharma hubDr Reddy’s Laboratory, Rockwell Automation, and other Telangana pharmaceutical companies plan to invest in Uttar Pradesh. They are attracted by the pro-pharma policies of the Yogi government. The..IndiaTimes - Published | |
Pharma, Healthcare Stocks Top Sectoral Gainers In TradeSun Pharma is the top Sensex gainer with gains of more than 3 per cent. Dr Reddy's is up more than 4 per cent. Max Healthcare is up 6 per cent.Zee News - Published | |
Dr Reddy’s acquires MenoLabs women’s wellness portfolio from AmyrisDr Reddy's Laboratories acquires Amyris Inc's MenoLabs portfolio, a women's health and dietary supplement brand, as part of Amyris' Chapter 11 bankruptcy sales proceedings. The acquisition includes..IndiaTimes - Published | |
United States: BPCIA Complaint Against Proposed Rituxan® Biosimilar DRL_RI Filed - Venable LLPOn November 17, 2023, Genentech, Inc., Hoffmann-La Roche Inc., and Biogen Inc. ("Plaintiffs") filed a BPCIA complaint ("Complaint") against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories SA..Mondaq - Published | |
Dr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023Dr Reddy's Laboratories becomes the first and only Indian pharma company on the S&P Dow Jones Sustainability World Index for 2023. The company also retains its position on the Dow Jones Sustainability..IndiaTimes - Published | |
Pharma faces USFDA heat, stocks downThe stocks of several pharma companies, including Dr Reddy's, Aurobindo Pharma, Cipla, Lupin, Sun Pharma, and Divi's Labs, have been lagging behind as the sensex and Nifty reach new highs. Dr Reddy's..IndiaTimes - Published | |
Dr Reddy's inks pact with Coya Therapeutics for investigational ALS therapy COYA 302Dr Reddy's Laboratories SA, a subsidiary of Dr Reddy's Laboratories, has signed a development and licence agreement with Coya Therapeutics Inc for the development and commercialisation of COYA 302, a..IndiaTimes - Published | Experts Urge for Preventive Lifestyle and Awareness on Treatment Options at the Osteoporosis Awareness SummitThe experts at the Osteoporosis Awareness Summit observed that osteoporosis is a public health emergency, however early screening and preventive lifestyle can help in proactive management and effective..NewsVoir - Published |
Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observationsOn Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug..IndiaTimes - Published | India: Delhi High Court Rules In Favour Of Reddy's Laboratories On Use Of The Mark RAZOFAST By Fast Cure Pharma - LexOrbisIn the recent case of Dr. Reddy's Laboratories Ltd vs Fast Cure Pharma, the plaintiff applied to the Delhi High Court for a permanent injunction restraining the defendant from manufacturing...Mondaq - Published |
Net Worth: Rs 20,0000 Crore, Age - 91, Goes To Office 6 Days A Week - Pratap Reddy's Incredible StoryThis article delves into Dr. Reddy's remarkable career, his dedication to the family's healthcare legacy, and his commitment to nurturing the succeeding generations of leaders.Zee News - Published | United States: § 112(a) Is A Priority In Decision To Institute IPR; Did Not Work To Say Petitioner Should Have Filed A PGR - Finnegan, Henderson, Farabow, Garrett & Dunner, LLPPetitioner Dr. Reddy's Laboratories challenged the patentability of several claims of U.S. Patent No. 11,110,087 ("the '087 patent") on 35 U.S.C. § 102 anticipation grounds. IPR2023-00052, Paper 7 at..Mondaq - Published |
USFDA accepts Dr Reddy's rituximab biosimilar candidate DRL_RI for substantive reviewIndiaTimes - Published | Dr Reddy’s forays into child nutrition spaceIndiaTimes - Published |
Dr Reddy's enters generics business in India marketIndiaTimes - Published | Aurobindo arm Eugia, Dr Reddy's & Hetero bag MPP sub-licence for generic leukemia drug NilotinibIndiaTimes - Published |
Dr Reddy’s forays into non-branded generics in Indian market with RGenXIndiaTimes - Published | Meet MSN Reddy, from chemist to net worth Rs 11400 crore, left leading MNC to build...Among the richest people of Hyderabad, Dr Reddy is the founder and chairman of MSN Labs, one of the fastest growing pharma companies in India that he built from scratch.DNA - Published |
iNutrimon Breaks New Ground in Nutrition Delivery ProcessThe web-based App *iNutrimon *that ensures physicians and clinical nutritionists to deliver optimum nutrition to patients recovering in healthcare set-ups has been endorsed by Indian Society for..NewsVoir - Published | Markets fall amid weak global equitiesFrom the Sensex pack, Titan, Mahindra & Mahindra, Maruti, HDFC, Dr Reddy's, Bajaj Finserv, Infosys, and HDFC Bank were the major laggards.IndiaTimes - Published |
Indian benchmark Indices end lower on Monday amid high global volatility, Sensex closes at 61,624From the Sensex pack, Dr Reddy's, ITC, Hindustan Unilever, State Bank of India, ICICI Bank, Nestle, Titan, Mahindra & Mahindra, Larsen & Toubro, and Reliance Industries were among the biggest laggards.Zee News - Published | Markets settle lower in volatile tradeFrom the Sensex pack, Dr Reddy's, ITC, Hindustan Unilever, State Bank of India, ICICI Bank, Nestle, Titan, Mahindra & Mahindra, Larsen & Toubro, and Reliance Industries were among the biggest laggards.IndiaTimes - Published |
Shrikant Chouhan: BUY Reliance and Dr Reddy’sTopNews - Published | Sudarshan Sukhani: BUY Hindalco, Dr Reddy’s, Lupin; SELL LIC HousingTopNews - Published |
Muhurat trading: Samvat 2079 begins on an auspicious noteEquity indices began Samvat 2079 on a positive note on Monday with both sensex and Nifty registering gains across all sectors. The 30-share BSE index jumped 524 points or 0.88% to close at 59,8312...IndiaTimes - Published | `Why wasn`t Jayalalithaa taken abroad, despite...`: SHOCKING FINDINGS of Arumugasamy panel against VK Sasikala, Dr Reddy, othersThe probe report - compiled by former Madras High Court Judge A Arumugasamy - has found Jayalalithaa's top aide VK Sasikala guilty of misconduct.Zee News - Published |
WEF recognises Dr Reddy's Hyderabad factory part of global lighthouse networknewKerala.com - Published | IQVIA announces partnership with Dr Reddy's Laboratories for CRM Solution for India Field ForcenewKerala.com - Published |
Goal Fest Conclave 2022 Catches Eyeballs as Veterans Like Anup Jalota, Anand Raj Anand, Rajesh Khattar and Madhushree Felicitate the Corporate LeadersGoal Fest Conclave 2022 held on the 30th of August at ITC Maratha, Mumbai began on a high-pitched note with the felicitation of Shri Anup Jalota by Mr. Saimik Sen, Editor-In-Chief, Herald Global. The..NewsVoir - Published | Sensex gains over 280 pts in early trade; Nifty above 17,600In contrast, Nestle, PowerGrid, Mahindra & Mahindra, Dr Reddy's and Hindustan Unilever were among the laggards in initial trade.Zee News - Published |
Sudarshan Sukhani: BUY HCL Technologies, Dr Reddy’s and NTPC; SELL L&TTopNews - Published | Dr Reddy's inks pact with Slayback Pharma of US to acquire rights for OTC ophthalmic productIndiaTimes - Published |
Ashish Chaturvedi: BUY Avenue Supermarts, Cummins India, Indian Hotels; SELL Dr Reddy’sTopNews - Published | Dr Reddy's Laboratories Q1 net profit jumps 108 per cent to Rs 1,188 crorenewKerala.com - Published |
Markets fall for 2nd day in row; Sensex declines 283 points in early tradeAmong the Sensex constituents, Dr Reddy's Lab, Nestle, Infosys, Asian Paints, HCL Technologies, TCS, Kotak Mahindra Bank and Larsen & Toubro were the biggest laggards in early trade.Zee News - Published | Dr Reddy's acquires branded, generic injectables from US-based Eton PharmaIndiaTimes - Published |
Sputnik boosters for private hospitals in Pune by June 25: Dr Reddy'sA spokesperson of Dr Reddy's, which distributes Sputnik V in India, told TOI on Thursday that it expected the booster stock of the vaccine would be available in one or two major hospitals in various..IndiaTimes - Published | Covid-19 vaccine: Dr Reddy's Lab to seek approval for Sputnik Light as universal booster doseIn September 2020, Dr. Reddy's partnered with Russian Direct Investment Fund to conduct clinical trials of Sputnik V and distribute vaccine in India.DNA - Published |
Sudarshan Sukhani: BUY Bajaj Finserv, Dr Reddy’s, Havells India; SELL Tata SteelTopNews - Published | |
